TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19913785

Group type: EXPERIMENTAL
Intervention: ENBD group
Number of subjects: 104

Group type: COMPARATOR
Intervention: no-ENBD group
Number of subjects: 104
Study: 17565585

Group type: EXPERIMENTAL
Intervention: Magnifying chromocolonoscopy
Number of subjects: 500

Group type: COMPARATOR
Intervention: Conventional chromocolonoscopy
Number of subjects: 500
Study: 15657158

Group type: EXPERIMENTAL
Intervention: Interferon treatment (6 to 9 million U, 3 times weekly for 26 to 88 weeks)
Number of subjects: 345

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 345
Study: 12038949

Group type: EXPERIMENTAL
Intervention: Intensive education
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Passive education
Number of subjects: 106

Group type: COMPARATOR
Intervention: Matched control group (no education)
Number of subjects: 106
Study: 9706913

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) 2 g
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Aprotinin 7 million KIU
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 150
Study: 8031109

Group type: EXPERIMENTAL
Intervention: C.A.R.E. program
Number of subjects: 195
Study: 2623215

Group type: EXPERIMENTAL
Intervention: Nicardipine administered intravenously or topically using iontophoresis or occlusive dressing
Number of subjects: 17
Study: 31376834

Group type: EXPERIMENTAL
Intervention: Automated marking (SensoMotoric Instruments - SMI)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Manual marking
Number of subjects: 132
Study: 28452885

Group type: EXPERIMENTAL
Intervention: Metabolic-targeted hypothermia treatment (MTHT) group, targeting 50% to 60% rest metabolic ratio
Number of subjects: 88

Group type: COMPARATOR
Intervention: Body temperature-targeted hypothermia treatment (BTHT) group, targeting body temperature of 32°C to 35°C
Number of subjects: 88
Study: 26151440

Group type: EXPERIMENTAL
Intervention: SibworkS program (n=30)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Waitlist control (n=26)
Number of subjects: 56
Study: 23250821

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination exercise
Number of subjects: 0
Study: 21584438

Group type: EXPERIMENTAL
Intervention: Resistance exercise combined with whole-body vibration at 30 Hz (R+V30)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Resistance exercise (R)
Number of subjects: 9
Study: 18438829

Group type: EXPERIMENTAL
Intervention: Sequential monotherapy (group 1)
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Step-up combination therapy (group 2)
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Initial combination therapy with methotrexate, sulfasalazine, and prednisone (group 3)
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Initial combination therapy with methotrexate and infliximab (group 4)
Number of subjects: 508
Study: 16284067

Group type: EXPERIMENTAL
Intervention: Indomethacin 100 mg rectally, given as three doses every 12 hours starting the night prior to embryo transfer
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group (standard specifications without indomethacin)
Number of subjects: 136
Study: 12676418

Group type: EXPERIMENTAL
Intervention: Multidimensional treatment protocol delivered by nurse practitioners (NP)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Usual medical care from primary care physician
Number of subjects: 203
Study: 10902984

Group type: EXPERIMENTAL
Intervention: Condensed milk + micronutrients (E)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Skimmed milk + micronutrients (M)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Skimmed milk (S)
Number of subjects: 136
Study: 8931393

Group type: EXPERIMENTAL
Intervention: Natural environment simulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Urban environment simulation
Number of subjects: 0
Study: 8451248

Group type: EXPERIMENTAL
Intervention: Pressure-relieving products (specific types not mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomised clinical trials of commonly used beds and overlays
Number of subjects: 0
Study: 3948474

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE), 0.5 mg im, twice a day from the day of surgery until full mobilization achieved
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine (DHE)
Number of subjects: 162
Study: 29889718

Group type: EXPERIMENTAL
Intervention: Noninvasive perfusion enhancement system
Number of subjects: 431

Group type: COMPARATOR
Intervention: Alternating pressure beds (control)
Number of subjects: 431
Study: 26391030

Group type: EXPERIMENTAL
Intervention: Multi-modal tobacco treatment education (MME)
Number of subjects: 1096

Group type: COMPARATOR
Intervention: Traditional tobacco treatment education (TE)
Number of subjects: 1096
Study: 24741578

Group type: EXPERIMENTAL
Intervention: TIL/IL-2
Number of subjects: 88

Group type: COMPARATOR
Intervention: IL-2
Number of subjects: 88
Study: 22368136

Group type: EXPERIMENTAL
Intervention: Early intervention group (peer mentoring on Trinity hypotensive ultrasound protocol between months 0 and 2)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Late intervention group (peer mentoring on Trinity hypotensive ultrasound protocol between months 2 and 4)
Number of subjects: 86
Study: 20210905

Group type: EXPERIMENTAL
Intervention: Continuous running
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Football
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Interval running
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Team sports
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Individual sports
Number of subjects: 6
Study: 18762327

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus HN001
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp lactis HN019
Number of subjects: 474

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 474
Study: 15556965

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study: 12127922

Group type: EXPERIMENTAL
Intervention: Hirudin
Number of subjects: 350

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 350
Study: 10613168

Group type: EXPERIMENTAL
Intervention: Dorsiflexion night splint for 3 months along with oral antiinflammatory medication, Achilles stretching exercises, and shoe recommendations
Number of subjects: 116

Group type: COMPARATOR
Intervention: Oral antiinflammatory medication, Achilles stretching exercises, and shoe recommendations for 1 month
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both treatment groups (with and without night splint)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Age older than 45 years
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Baseline Short Form 36 data
Number of subjects: 116
Study: 7861873

Group type: EXPERIMENTAL
Intervention: Diet low in saturated fat and cholesterol
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Control (unrestricted diet)
Number of subjects: 1062
Study: 1773711

Group type: EXPERIMENTAL
Intervention: Purified pork insulin (PPI)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Human insulin (HI)
Number of subjects: 9
Study: 7002185

Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g four times daily for 2 days, then 0.5 g four times daily for the next 2 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 24
Study: 30171655

Group type: EXPERIMENTAL
Intervention: PR-fampridine
Number of subjects: 55
Study: 28692772

Group type: EXPERIMENTAL
Intervention: ReS2 lateral heterojunctions to WS2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vertically stacked ReS2 on WS2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Degree of anisotropy of ReS2 on WS2
Number of subjects: 0
Study: 26555330

Group type: EXPERIMENTAL
Intervention: Individual intervention
Number of subjects: 21

Group type: COMPARATOR
Intervention: Group intervention
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Individual and Group interventions
Number of subjects: 21
Study: 25364070

Group type: EXPERIMENTAL
Intervention: High cognitive workload (HW) + Sleep Restriction (SR)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Moderate cognitive workload (MW) + Sleep Restriction (SR)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: High cognitive workload (HW) + No Sleep Restriction (NSR)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Moderate cognitive workload (MW) + No Sleep Restriction (NSR)
Number of subjects: 63
Study: 22139541

Group type: EXPERIMENTAL
Intervention: Tongxinluo Capsule
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Kangxin Capsule
Number of subjects: 239
Study: 19098197

Group type: EXPERIMENTAL
Intervention: 3D sonography with perflubutane contrast agent
Number of subjects: 84
Study: 17684211

Group type: EXPERIMENTAL
Intervention: Zinc sulfate 10 mg tablet twice a day during hospitalization
Number of subjects: 299

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study: 15051694

Group type: EXPERIMENTAL
Intervention: Hemispheric TIA
Number of subjects: 603

Group type: COMPARATOR
Intervention: Hemispheric stroke
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Hemispheric TIA with infarct on brain imaging
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Hemispheric TIA with intracranial major-artery disease
Number of subjects: 603
Study: 11124350

Group type: COMPARATOR
Intervention: Closed-container condition
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Inside-container condition
Number of subjects: 2

Group type: COMPARATOR
Intervention: Behind-container condition
Number of subjects: 2
Study: 9205830

Group type: EXPERIMENTAL
Intervention: Eprosartan 200 mg orally every 12 h for 4 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Digoxin 0.6 mg orally alone
Number of subjects: 12
Study: 8166054

Group type: EXPERIMENTAL
Intervention: Various therapies designed to impact on progression of heart failure
Number of subjects: 0
Study: 3308164

Group type: EXPERIMENTAL
Intervention: oral cyclical combination of 2 mg estradiol valerate and cyproterone acetate
Number of subjects: 110

Group type: COMPARATOR
Intervention: oral placebo
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: percutaneous 17 beta‐estradiol, supplemented by 200 mg oral progesterone during the second year
Number of subjects: 110

Group type: COMPARATOR
Intervention: percutaneous placebo cream
Number of subjects: 110
Study: 30124566

Group type: EXPERIMENTAL
Intervention: Positive conditioning task (repeatedly pairing self‐relevant words with an image of a smiling face)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Neutral conditioning task (repeatedly pairing self‐relevant words with random smiling, angry, or neutral faces)
Number of subjects: 28
Study: 27342215

Group type: EXPERIMENTAL
Intervention: Facility-based care plus community-based rehabilitation
Number of subjects: 182

Group type: COMPARATOR
Intervention: Facility-based care alone
Number of subjects: 182
Study: 23732264

Group type: EXPERIMENTAL
Intervention: Plasma‐Lyte A
Number of subjects: 46

Group type: COMPARATOR
Intervention: 0.9% NaCl
Number of subjects: 46
Study: 22789911

Group type: EXPERIMENTAL
Intervention: Telecare device kit including monitoring of oxygen saturation, pulse rate, and respiration rate, with medication and purse-lip breathing reminders.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Telecare device kit
Number of subjects: 40

Group type: COMPARATOR
Intervention: No extra care
Number of subjects: 40
Study: 20804255

Group type: EXPERIMENTAL
Intervention: Captain's Log CCRT training (10 sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 60
Study: 18262446

Group type: EXPERIMENTAL
Intervention: Endovascular repair (EVAR)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 123
Study: 16160624

Group type: EXPERIMENTAL
Intervention: Sertraline (150 mg daily)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (200 mg daily)
Number of subjects: 93
Study: 12749829

Group type: EXPERIMENTAL
Intervention: Oxazolidinones
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cationic peptides
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lipopeptide antibiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peptide deformylase inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pleuromutilins
Number of subjects: 0
Study: 10587868

Group type: EXPERIMENTAL
Intervention: Breath-hold contrast-enhanced MR angiography using a multiecho gradient-echo technique
Number of subjects: 16
Study: 8726671

Group type: EXPERIMENTAL
Intervention: Intraoperative extracorporeal ultrafiltration and postoperative autotransfusion of shed mediastinal blood
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Autotransfusion only
Number of subjects: 3

Group type: COMPARATOR
Intervention: No interventions (control group)
Number of subjects: 3
Study: 1928809

Group type: EXPERIMENTAL
Intervention: L-dopa 250 mg administered orally
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Domperidone 20 mg orally (peripheral DA2 dopamine receptor blocker)
Number of subjects: 36
Study: 6137167

Group type: COMPARATOR
Intervention: Lormetazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lormetazepam (oral and intravenous)
Number of subjects: 0
Study: 30700332

Group type: EXPERIMENTAL
Intervention: One-lead handheld ECG recordings twice daily and extra recordings in case of palpitations.
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Routine clinical practice for AF detection.
Number of subjects: 1600
Study: 29668467

Group type: COMPARATOR
Intervention: General anesthesia only (Group I)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bilateral ultrasound guided rectus sheath block with 40 ml of 0.25% bupivacaine after induction of general anesthesia (Group II)
Number of subjects: 60
Study: 26997419

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 24
Study: 25118980

Group type: EXPERIMENTAL
Intervention: OPCAB surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: On-pump surgery
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Postoperative selenium levels
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Selenium levels
Number of subjects: 40
Study: 22818552

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Artesunate plus mefloquine (A+M)
Number of subjects: 150
Study: 18801760

Group type: EXPERIMENTAL
Intervention: Adalimumab plus methotrexate
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: Adalimumab monotherapy
Number of subjects: 768

Group type: COMPARATOR
Intervention: Methotrexate monotherapy
Number of subjects: 768
Study: 17141580

Group type: EXPERIMENTAL
Intervention: LC‐MS/MS bioanalytical method for clopidogrel
Number of subjects: 0
Study: 15105384

Group type: EXPERIMENTAL
Intervention: Hysteroscopic surgery plus intrauterine application of ACP gel (10 ml)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Hysteroscopic surgery alone (control group)
Number of subjects: 132
Study: 11437862

Group type: EXPERIMENTAL
Intervention: Troglitazone (400 mg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Glibenclamide (5.0 mg/day)
Number of subjects: 32
Study: 9602584

Group type: EXPERIMENTAL
Intervention: Intraoperative blood salvage (group 1)
Number of subjects: 34
Study: 8020815

Group type: EXPERIMENTAL
Intervention: 40 mg omeprazole once daily
Number of subjects: 104

Group type: COMPARATOR
Intervention: 2 g sucralfate twice daily
Number of subjects: 104
Study: 2920066

Group type: EXPERIMENTAL
Intervention: GE + GU (gemfibrozil + guar gum) 15 g/day
Number of subjects: 29

Group type: COMPARATOR
Intervention: GE + PL (gemfibrozil + placebo)
Number of subjects: 29
Study: 1149485

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nalorphine
Number of subjects: 0
Study: 29206666

Group type: EXPERIMENTAL
Intervention: Diclofenac phonophoresis with combined therapy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Diclofenac phonophoresis
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ultrasound (US) with coupling gel
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham US
Number of subjects: 100
Study: 27710914

Group type: EXPERIMENTAL
Intervention: Moderate iodine deficiency (ID) group
Number of subjects: 196
Study: 23922211

Group type: EXPERIMENTAL
Intervention: Symbiotic mixture (Probinul(®))
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 22741256

Group type: EXPERIMENTAL
Intervention: Dragon-tiger fighting needling method (group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Uniform reinforcing‐reducing method (group B)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intermediate frequency physiotherapy (group C)
Number of subjects: 90
Study: 20818862

Group type: EXPERIMENTAL
Intervention: sipuleucel-T
Number of subjects: 512

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 512
Study: 18455403

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Tracheal intubation
Number of subjects: 53
Study: 16481224

Group type: EXPERIMENTAL
Intervention: Levofloxacin 750 mg alone
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Levofloxacin 750 mg with 2‐h spaced calcium carbonate 500 mg thrice daily
Number of subjects: 5
Study: 12795568

Group type: EXPERIMENTAL
Intervention: Behavioral family counseling (BFC) plus individual treatment (naltrexone daily in presence of family member)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Individual-based treatment (IBT; naltrexone with no family involvement)
Number of subjects: 124
Study: 11078282

Group type: EXPERIMENTAL
Intervention: Increasing low levels of HDL cholesterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decreasing elevated levels of LDL cholesterol
Number of subjects: 0
Study: 9479794

Group type: EXPERIMENTAL
Intervention: General practitioner medical records
Number of subjects: 150
Study: 2066170

Group type: EXPERIMENTAL
Intervention: Counseling with a self-help manual and three to eight 15- to 20-min counseling sessions on alternate days while in hospital
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard care (no additional counseling)
Number of subjects: 74
Study: 6342840

Group type: EXPERIMENTAL
Intervention: Propranolol therapy
Number of subjects: 3837

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3837
Study: 31662515

Group type: EXPERIMENTAL
Intervention: Local anesthesia during breast‐conserving surgery
Number of subjects: 56

Group type: COMPARATOR
Intervention: General anesthesia during breast‐conserving surgery
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (General anesthesia)
Number of subjects: 56
Study: 29895587

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 3497

Group type: COMPARATOR
Intervention: PARADIGM-HF trial participants
Number of subjects: 3497
Study: 26856926

Group type: EXPERIMENTAL
Intervention: DP-R202 300 mg once daily
Number of subjects: 151

Group type: COMPARATOR
Intervention: Anplag Tab 100 mg TID
Number of subjects: 151
Study: 25282317

Group type: EXPERIMENTAL
Intervention: High-intensity statin therapy (rosuvastatin 40 mg or atorvastatin 80 mg)
Number of subjects: 1881
Study: 22704854

Group type: EXPERIMENTAL
Intervention: Sustained-release morphine (average end titration dose of 78 mg morphine/d)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Weight-matched placebo capsules
Number of subjects: 103
Study: 19449118

Group type: EXPERIMENTAL
Intervention: Neoadjuvant LHRH agonist plus estramustine phosphate (EMP) for 6 months until completion of the 3D-CRT (EMP group, n = 20)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Neoadjuvant LHRH agonist alone (LHRH group, n = 19)
Number of subjects: 39
Study: 17035932

Group type: EXPERIMENTAL
Intervention: Spironolactone 300 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 15721570

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) alone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) and Attachment Based Family Therapy (ABFT)
Number of subjects: 19
Study: 12049621

Group type: EXPERIMENTAL
Intervention: BQ-123 (50 nmol/min for 60 min)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: BQ-123 (300 nmol/min for 5 min followed by saline for 55 min)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP; 12 nmol/min for 60 min)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ET-1 (10 pmol/min for 7 min)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: NA (120 pmol/min for 7 min)
Number of subjects: 6
Study: 10439495

Group type: EXPERIMENTAL
Intervention: Cardiovascular prevention programme including opportunistic screening and individually designed follow-up.
Number of subjects: 5622
Study: 8607621

Group type: EXPERIMENTAL
Intervention: Oral 5'-DFUR
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Intratumor OK-432
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Oral 5'-DFUR plus intratumor and intracutaneous OK-432
Number of subjects: 49

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 49
Study: 2105625

Group type: EXPERIMENTAL
Intervention: recombinant tissue plasminogen activator (rt‐PA)
Number of subjects: 288
Study: 108804

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate inhalation solution
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate powder
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo ampoule
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 10
Study: 29619797

Group type: EXPERIMENTAL
Intervention: H3 (every 3 seconds)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: H1 (every second)
Number of subjects: 9
Study: 26744141

Group type: EXPERIMENTAL
Intervention: Fluoridated implants in the maxilla
Number of subjects: 48